Y. W. Chen, J. Xu, Yi Wang, H. Yan, J. L. Gao
{"title":"中国公众对COVID-19疫苗的偏好和接种意愿","authors":"Y. W. Chen, J. Xu, Yi Wang, H. Yan, J. L. Gao","doi":"10.3969/j.issn.1672-8467.2021.05.002","DOIUrl":null,"url":null,"abstract":"Objective: To understand public preference and immunization willingness for COVID-19 vaccine in China, and analyze influence factors, provide references for sufficient vaccination coverage. Methods: An online D-efficient discrete choice experiment was conducted from Jan 5, 2021 to Jan 12, 2021, in 1 241 people (with 1066 valid feedbacks), using choice sets with 5 vaccine attributes:protection rate, adverse effect, protection duration, convenience of vaccination, and out-of-pocket cost.Conditional Logit and panel mixed Logit models were used to analyze the effect of vaccine attributes on preferences, while random-effects Logit model was used to analyze the effect of vaccine attributes on vaccination willingness. Results: The COVID-19 vaccine with high protection rate(βefficacy 95%=1.76, P<0.001), low adverse effects(βlow risk=1.93, P<0.001), long protection duration (β5 years=0.59, P<0.001), convenient vaccination process(βconvenient=0.53, P<0.001), and less cost(βcost=0.14, P<0.001) was preferred by the public. Conclusion: Public preference and vaccination willingness for COVID-19 vaccine influenced by all 5 vaccine attributes (protection rate, adverse effect, protection duration, convenience of vaccination, and out-of-pocket cost).The efficacy and safety of the vaccine had the most significant impact. © 2021, Editorial Department of Fudan University Journal of Medical Sciences. All right reserved.","PeriodicalId":12635,"journal":{"name":"复旦学报(医学版)","volume":"48 1","pages":"578-585"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Public preference and vaccination willingness for COVID-19 vaccine in China\",\"authors\":\"Y. W. Chen, J. Xu, Yi Wang, H. Yan, J. L. Gao\",\"doi\":\"10.3969/j.issn.1672-8467.2021.05.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: To understand public preference and immunization willingness for COVID-19 vaccine in China, and analyze influence factors, provide references for sufficient vaccination coverage. Methods: An online D-efficient discrete choice experiment was conducted from Jan 5, 2021 to Jan 12, 2021, in 1 241 people (with 1066 valid feedbacks), using choice sets with 5 vaccine attributes:protection rate, adverse effect, protection duration, convenience of vaccination, and out-of-pocket cost.Conditional Logit and panel mixed Logit models were used to analyze the effect of vaccine attributes on preferences, while random-effects Logit model was used to analyze the effect of vaccine attributes on vaccination willingness. Results: The COVID-19 vaccine with high protection rate(βefficacy 95%=1.76, P<0.001), low adverse effects(βlow risk=1.93, P<0.001), long protection duration (β5 years=0.59, P<0.001), convenient vaccination process(βconvenient=0.53, P<0.001), and less cost(βcost=0.14, P<0.001) was preferred by the public. Conclusion: Public preference and vaccination willingness for COVID-19 vaccine influenced by all 5 vaccine attributes (protection rate, adverse effect, protection duration, convenience of vaccination, and out-of-pocket cost).The efficacy and safety of the vaccine had the most significant impact. © 2021, Editorial Department of Fudan University Journal of Medical Sciences. All right reserved.\",\"PeriodicalId\":12635,\"journal\":{\"name\":\"复旦学报(医学版)\",\"volume\":\"48 1\",\"pages\":\"578-585\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"复旦学报(医学版)\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3969/j.issn.1672-8467.2021.05.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"复旦学报(医学版)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3969/j.issn.1672-8467.2021.05.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
Public preference and vaccination willingness for COVID-19 vaccine in China
Objective: To understand public preference and immunization willingness for COVID-19 vaccine in China, and analyze influence factors, provide references for sufficient vaccination coverage. Methods: An online D-efficient discrete choice experiment was conducted from Jan 5, 2021 to Jan 12, 2021, in 1 241 people (with 1066 valid feedbacks), using choice sets with 5 vaccine attributes:protection rate, adverse effect, protection duration, convenience of vaccination, and out-of-pocket cost.Conditional Logit and panel mixed Logit models were used to analyze the effect of vaccine attributes on preferences, while random-effects Logit model was used to analyze the effect of vaccine attributes on vaccination willingness. Results: The COVID-19 vaccine with high protection rate(βefficacy 95%=1.76, P<0.001), low adverse effects(βlow risk=1.93, P<0.001), long protection duration (β5 years=0.59, P<0.001), convenient vaccination process(βconvenient=0.53, P<0.001), and less cost(βcost=0.14, P<0.001) was preferred by the public. Conclusion: Public preference and vaccination willingness for COVID-19 vaccine influenced by all 5 vaccine attributes (protection rate, adverse effect, protection duration, convenience of vaccination, and out-of-pocket cost).The efficacy and safety of the vaccine had the most significant impact. © 2021, Editorial Department of Fudan University Journal of Medical Sciences. All right reserved.